Clinical Trial Update: Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing LXI-15028 with lansoprazole for duodenal ulcer has completed, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer

Drugs mentioned

• LXI-15028

Snippet

Sponsor: Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | Conditions: Duodenal Ulcer | Phase 3 | Status: COMPLETED